Analytical method development and validation of empagliflozin via RP-HPLC and UV spectrophotometric technique
Journal of Integrative and Translational Biomedicine · 2026
DOI: 10.67316/jintb.v1.i1.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative and Translational Biomedicine, 2026. Verfasst von Prachi Dwivedi und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In the present study, UV spectrophotometry and reverse-phase high-performance liquid chromatography (RP-HPLC) were utilised to develop and validate a quantitative determination of empagliflozin, followed by its estimation in pharmaceutical dosage forms.
Methods
The design of experiment (DoE) was used to optimise RP-HPLC method for improved accuracy and precision. Similarly, for UV spectrophotometry, phosphate buffer pH 7.4 was selected as solvent. Reverse-phase elution was employed to achieve efficient chromatographic separations using a Shimadzu HPLC C18G column (250×4.6 mm). The mobile phase used for RP-HPLC is composed of acetonitrile: methanol: ortho-phosphoric acid in the ratio 50:20:30 v/v at flow rate of 1.0 mL/min. Furthermore, investigations on forced degradation were conducted to demonstrate stability of technique. ICH guidelines were followed in validation of established procedures.
Results
The detection was carried out within the range of 200-400 nm, revealing an absorption maximum at 223 nm. The linearity range for empagliflozin was 4-14 µg/mL with a correlation coefficient of 0.9930. The retention time was found to be 3.38 min with a linearity range of 10-60 ppm and a correlation coefficient of 0.9966. The statistical validation of evolved methods was conducted to assess linearity, precision, accuracy, robustness, ruggedness, and detection, further subjecting system to hydrolytic, oxidative, photolytic, and thermal degradation stress conditions. Drug showed minute degradation under oxidative stress conditions, whereas all other conditions were found to be satisfactory.
Conclusion
The present developed method is simple, fast, and economical. This method can be utilised to quantify empagliflozin in various dosage forms.
Zitieren
APA
Dwivedi, P., Raviraj, C., Charyulu, R. N., Kumar, P., S., S. D., & Lobo, C. L. (2026). Analytical method development and validation of empagliflozin via RP-HPLC and UV spectrophotometric technique. Journal of Integrative and Translational Biomedicine. https://doi.org/10.67316/jintb.v1.i1.4
Vancouver
Dwivedi P, Raviraj C, Charyulu RN, Kumar P, S. SD, Lobo CL. Analytical method development and validation of empagliflozin via RP-HPLC and UV spectrophotometric technique. Journal of Integrative and Translational Biomedicine. 2026. doi:10.67316/jintb.v1.i1.4
BibTeX
@article{Dwivedi2026,
author = {Dwivedi, Prachi and Raviraj, Chaithra and Charyulu, R. Narayana and Kumar, Pankaj and S., Sandeep D. and Lobo, Cynthia Lizi},
title = {Analytical method development and validation of empagliflozin via RP-HPLC and UV spectrophotometric technique},
journal = {Journal of Integrative and Translational Biomedicine},
year = {2026},
doi = {10.67316/jintb.v1.i1.4}
}
EUVIMED